Table 3.
Multivariate analysis to elucidate factors associated with arterial β-HB and AcAc/β-HB ratio in all HD patients (n = 49)
| Log albumin | Uric acid | |||||
|---|---|---|---|---|---|---|
| Model 1 | Model 2 | Model 3 | Model 1 | Model 2 | Model 3 | |
| Age | −0.172 | −0.164 | − 0.165 | 0.058 | 0.067 | 0.067 |
| Gender (M/F, 1/2) | −0.0004 | 0.059 | 0.042 | 0.163 | 0.221 | 0.217 |
| DM (−/+, 1/2) | 0.313 | 0.386* | 0.368* | −0.0004 | 0.073 | 0.068 |
| Log (HD duration) | −0.256 | −0.300* | − 0.319* | 0.310* | 0.237 | 0.232 |
| Log β-HB | −0.092 | – | 0.244 | −0.333* | – | 0.061 |
| Log AcAc/ β-HB ratio | – | 0.300* | 0.463* | – | 0.533* | 0.578* |
| p (R2) | 0.0582 (0.214) | 0.0128 (0.278) | 0.0159 (0.299) | 0.0404 (0.230) | 0.0013 (0.362) | 0.0029 (0.364) |
*Statistically significant difference (p < 0.05)